CN103694184B - 一种奥替拉西钾的精制方法 - Google Patents
一种奥替拉西钾的精制方法 Download PDFInfo
- Publication number
- CN103694184B CN103694184B CN201310630583.1A CN201310630583A CN103694184B CN 103694184 B CN103694184 B CN 103694184B CN 201310630583 A CN201310630583 A CN 201310630583A CN 103694184 B CN103694184 B CN 103694184B
- Authority
- CN
- China
- Prior art keywords
- oteracil potassium
- milliliters
- grams
- crude product
- potassium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229950000193 oteracil Drugs 0.000 title claims abstract description 76
- 238000000034 method Methods 0.000 title claims abstract description 30
- 238000000746 purification Methods 0.000 title claims abstract description 22
- RYYCJUAHISIHTL-UHFFFAOYSA-N 5-azaorotic acid Chemical compound OC(=O)C1=NC(=O)NC(=O)N1 RYYCJUAHISIHTL-UHFFFAOYSA-N 0.000 title claims abstract 10
- 239000012043 crude product Substances 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 238000005406 washing Methods 0.000 claims abstract description 29
- 239000000047 product Substances 0.000 claims abstract description 11
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000007670 refining Methods 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 11
- 229960000583 acetic acid Drugs 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000012362 glacial acetic acid Substances 0.000 claims description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 10
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical class [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052794 bromium Inorganic materials 0.000 claims description 6
- -1 filter Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 235000007715 potassium iodide Nutrition 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 3
- IAPCTXZQXAVYNG-UHFFFAOYSA-M Potassium 2,6-dihydroxytriazinecarboxylate Chemical compound [K+].[O-]C(=O)C1=NC(=O)NC(=O)N1 IAPCTXZQXAVYNG-UHFFFAOYSA-M 0.000 description 67
- 239000002253 acid Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229960001701 chloroform Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003637 basic solution Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229960004839 potassium iodide Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WFWLQNSHRPWKFK-ZCFIWIBFSA-N tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 description 2
- 229960001674 tegafur Drugs 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000029785 Orotate phosphoribosyltransferase Human genes 0.000 description 1
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 208000000649 small cell carcinoma Diseases 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/20—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with no nitrogen atoms directly attached to a ring carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310630583.1A CN103694184B (zh) | 2013-12-02 | 2013-12-02 | 一种奥替拉西钾的精制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310630583.1A CN103694184B (zh) | 2013-12-02 | 2013-12-02 | 一种奥替拉西钾的精制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103694184A CN103694184A (zh) | 2014-04-02 |
CN103694184B true CN103694184B (zh) | 2015-08-05 |
Family
ID=50355874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310630583.1A Expired - Fee Related CN103694184B (zh) | 2013-12-02 | 2013-12-02 | 一种奥替拉西钾的精制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103694184B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105801505B (zh) * | 2014-12-31 | 2018-06-19 | 四川科伦药物研究院有限公司 | 一种由奥替拉西钾制备5-氮杂尿嘧啶的方法及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0957096A1 (en) * | 1998-05-11 | 1999-11-17 | SUMIKA FINE CHEMICALS Co., Ltd. | Method for producing potassium oxonate |
CN101475539A (zh) * | 2009-02-11 | 2009-07-08 | 鲁南制药集团股份有限公司 | 一种制备高纯度氧嗪酸钾的精制方法 |
CN102250025A (zh) * | 2011-05-18 | 2011-11-23 | 深圳万乐药业有限公司 | 一种适合工业化生产奥替拉西钾的制备方法 |
CN102746244A (zh) * | 2012-07-27 | 2012-10-24 | 南京正大天晴制药有限公司 | 一种奥替拉西钾的精制方法 |
-
2013
- 2013-12-02 CN CN201310630583.1A patent/CN103694184B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0957096A1 (en) * | 1998-05-11 | 1999-11-17 | SUMIKA FINE CHEMICALS Co., Ltd. | Method for producing potassium oxonate |
CN101475539A (zh) * | 2009-02-11 | 2009-07-08 | 鲁南制药集团股份有限公司 | 一种制备高纯度氧嗪酸钾的精制方法 |
CN102250025A (zh) * | 2011-05-18 | 2011-11-23 | 深圳万乐药业有限公司 | 一种适合工业化生产奥替拉西钾的制备方法 |
CN102746244A (zh) * | 2012-07-27 | 2012-10-24 | 南京正大天晴制药有限公司 | 一种奥替拉西钾的精制方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103694184A (zh) | 2014-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105330627B (zh) | 高选择性制备呋喃铵盐的方法 | |
CN106349245B (zh) | 一种磷酸西格列汀杂质及其制备方法和用途 | |
CN112441952B (zh) | 一种大麻二酚-3-磺酸及其制备方法和应用、大麻二酚衍生物 | |
CN106478600A (zh) | 一种兰索拉唑的精制方法 | |
CN103204819B (zh) | 氘代地西泮及其制备方法 | |
CN104672291B (zh) | 一种没食子酸植物甾醇酯的制备方法 | |
CN106146560B (zh) | 一种高纯度磷酸特地唑胺的精制方法 | |
CN103694184B (zh) | 一种奥替拉西钾的精制方法 | |
CN101475539B (zh) | 一种制备高纯度氧嗪酸钾的精制方法 | |
CN103360462B (zh) | 一种丙氨酰谷氨酰胺原料药的精制方法 | |
CN103626697B (zh) | 一种2‑氯‑4‑三氟甲基‑3‑氰基吡啶的制备方法 | |
CN102746244B (zh) | 一种奥替拉西钾的精制方法 | |
CN103408487B (zh) | 一种吉莫斯特的精制方法 | |
CN103113294A (zh) | 瑞巴派特的合成方法 | |
CN106279207A (zh) | 一种头孢地尼的合成方法 | |
CN103588780A (zh) | 斑蝥素酸钡及其制备方法 | |
CN101220012A (zh) | 一种合成多取代4-氟-2(5h)-呋喃酮的方法 | |
CN113135862A (zh) | 一种6-氟-3-羟基吡嗪-2-羧酸的合成方法 | |
CN105017051A (zh) | 一种溴芬酸钠倍半水合物的精制方法 | |
CN104447285B (zh) | 一种乙酰丙酸钙一水合物的晶型 | |
CN103923142B (zh) | 一种罗红霉素中间体的制备方法 | |
CN102977117A (zh) | 一种6-溴-2,2-二甲基-2h-吡啶并[3,2-b][1,4]恶嗪-3(4h)-酮的合成方法 | |
CN104151229B (zh) | 一种(S)-(-)-氨氯地平-半-D-酒石酸-单-DMSO-d6配合物的制备方法 | |
CN103588778A (zh) | 斑蝥素酸锶及其制备方法 | |
CN103588779A (zh) | 斑蝥素酸锰及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 257335, No. 262, Tsing Yi Road, rubber industrial zone, Da Wang Town, Guangrao County, Shandong, Dongying Applicant after: Yongtai, Shandong Group Co., Ltd Address before: 257335 Guangrao City, Dongying Province town of Rubber Industrial Park Applicant before: Shandong Yongtai Chemical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SHANDONG YONGTAI CHEMICAL ENGINEERING CO., LTD. TO: SHANDONG YONGTAI GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20170216 Granted publication date: 20150805 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20170816 Granted publication date: 20150805 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20170816 Granted publication date: 20150805 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20200816 Granted publication date: 20150805 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150805 Termination date: 20171202 |